ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 13 Feb, 2026 · 13:50 IST

Alkem Laboratories Limited has informed the Exchange about Outcome of Board Meeting held on 13th February, 2026

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-7.8%Reaction day
₹5857.00
prior close
₹5722.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.7%-6.1% vs market
Pharmaceuticals peers, median of 156sector-0.9%-6.9% vs sector

On the reaction day the stock moved 6.1 pts less than Nifty Midcap 150 and 6.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-1.0
15m
-2.2
30m
-4.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-7.8-1.7-6.1-0.9-6.9
Next day
-6.5-1.2-5.3-1.4-5.1
2d
-6.8-1.0-5.8-0.9-5.9
3d
-6.8-0.4-6.4-0.5-6.3
4d
-8.1-2.0-6.1-2.0-6.0
5d
-7.9-1.5-6.4-2.2-5.7
1w
-6.4-1.9-4.5-2.8-3.6
15d
-6.6-6.8+0.2-6.9+0.3
1m
-8.1-9.1+1.0-8.9+0.8
2m
-8.7-4.8-3.8-3.4-5.2
3m
-6.9-0.7-6.2+0.9-7.9
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Labs' board, meeting on 13 February 2026, approved standalone and consolidated unaudited results for Q3 and nine months ended 31 December 2025. Consolidated revenue from operations for Q3 stood at Rs. 37,368.2 million, up from Rs. 33,742.8 million in the same quarter last year. Net profit for Q3 was Rs. 6,530.3 million versus Rs. 6,407.9 million a year earlier, with nine-month profit at Rs. 21,000.5 million. The board declared an interim dividend of Rs. 43 per share (2150% on face value of Rs. 2), with record date 20 February 2026 and payment from 6 March 2026. The company also booked a Rs. 527.9 million exceptional charge in Q3 related to the new Labour Codes notified in November 2025.

Likely market impact

Steady revenue and profit growth with continued dividend payouts should support shareholder confidence; however, the Labour Code-related exceptional charge is a one-time drag on Q3 earnings.